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ABSTRACT: Reported herein is a dual nickel- and photoredox-catalysed modular approach for the preparation of enantioenriched 
N-benzylic heterocycles. α-Heterocyclic carboxylic acids, easily obtainable from common commercial material, are reported as suit-
able substrates for a decarboxylative strategy in conjunction with a chiral pyridine-oxazoline (PyOx) ligand, providing quick access 
to enantioenriched drug-like products. The presence of a directing group on the heterocyclic moiety is shown to be beneficial, afford-
ing improved stereoselectivity in a number of cases. 
N-Benzylic heterocycles constitute an important class of het-
erocyclic compounds in the pharmaceutical industry, with nu-
merous examples of commercial drugs and bioactive mole-
cules.1 A subset of these molecules contain chirality at the α-
position of the benzylic moiety (Figure 1), with important ef-
fects on their pharmacological properties. For example, the an-
aesthetic drug etomidate contains an imidazole ring with a chi-
ral N-benzylic substituent;2 the anaesthetic potency is one order 
of magnitude higher for the (R) enantiomer compared to the (S)
enantiomer.3 Their preparation typically involves the synthesis 
of the heterocycle from a chiral benzylic amine,4,5 or the nucle-
ophilic substitution of a suitable chiral precursor with the nitro-
gen heterocycle.6 While these methods can be effective, the lack 
of modularity hampers quick access to different structures, ne-
cessitating the preparation of an enantiopure precursor for every 
desired entry. Moreover, substitution using heterocycles with 
multiple nitrogen atoms can lead to the formation of isomers,7 
resulting in low yields and difficulty of separation while con-
suming such precious chiral precursors. A modular approach, 
allowing the use of prochiral and easily obtainable substrates, 
is thus desirable. 
 
Figure 1. Examples of pharmaceutically-relevant compounds bear-
ing a chiral N-benzylic heterocycle motif. 
Photoredox catalysis is certainly one of the most interesting 
and active fields of research of the moment.8 Upon visible light 
irradiation, reactive radical species can be generated in excep-
tionally mild conditions. Moreover, recent efforts in coupling 
this mode of activation with nickel catalysis have further en-
larged the scope of the field.9 Efficient cross-coupling reactions 
can be obtained between aryl halides and a variety of radical 
sources: relevant examples include carboxylates,10 alkyltri-
fluoroborates11 and alkyldihydropyridines.12 Even simple C–H 
bonds, within proper hydrogen atom transfer (HAT) manifolds, 
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can engage into Ni–radical cross-couplings.13 While it is possi-
ble to generate prochiral secondary alkyl radicals from such 
precursors, the field of enantioselective Ni–photoredox cross-
couplings is still under-explored.14 In 2014, the Molander group 
described the first example of the use of alkyltrifluoroborate 
salts in Ni–photoredox cross-couplings, showing that stere-
ocontrol can be obtained with a chiral bioxazoline as ligand 
(Scheme 1a).11a Starting from carboxylate salts,  the MacMillan 
and Fu groups demonstrated how the use of a chiral cyano-bis-
oxazoline ligand was effective in catalysing an enantioselective 
decarboxylative cross-coupling with carbamate-protected ami-
noacids (Scheme 1b).10d During the preparation of this manu-
script, Lu’s group also reported an efficient asymmetric cross-
coupling leading to 1,1-diarylalkanes, with a chiral biimidazo-
line as ligand.15 Similar systems were used by other groups in 
isolated examples of enantioselective cross-coupling reac-
tions.11d,13e,16 
Here we report a Ni–photoredox cross-coupling-based ap-
proach for the preparation of chiral N-benzylic heterocycles 
(Scheme 1c), which have been rarely considered within these 
catalytic manifolds.17 α-Heterocyclic carboxylic acids have 
been successfully coupled with aryl bromides, while the intro-
duction of a pyridine-oxazoline (PyOx) chiral ligand allowed 
sterocontrol in such C–C bond-forming reaction where previous 
conditions failed.10d We also found the presence of a directing 
handle on the heterocyclic moiety to be important for improving 
stereoselectivity. Chiral, drug-like compounds could thus be 
prepared in a simple, modular fashion from easily obtainable 
materials.  
Scheme 1. Enantioselective Ni-photoredox cross-couplings 
and approach to the synthesis of N-benzylic heterocycles. 
 
Our investigation started with an evaluation of ligands for the 
conversion of pyrrole carboxylic acid 1a (prepared from L-ala-
nine) and 4-bromobenzonitrile into chiral benzylic pyrrole 2a. 
The reaction was conducted using DMF as solvent, 4CzIPN as 
photocatalyst,18 NiCl2·DME as nickel source and Cs2CO3 as 
base under blue light irradiation (λirr = 450-455 nm).  Among 
the different nitrogen- and phosphorous-containing ligands ex-
amined (see ESI, Table S1), pyridine-oxazoline (PyOx)19 ligand 
L1 emerged as effective and versatile, providing 50% yield and 
69:31 e.r. (Table 1, entry 1). During our optimisation work we 
observed that cyano-bis-oxazoline L6 and related ligands are 
also competent catalysts, affording satisfactory levels of enan-
tioselectivity (22:78 e.r., entry 2). However, they show reduced 
reactivity and extremely narrow scope, which prompted us to 
exclude them from further analysis (see ESI). 
Table 1. Optimisation: selection of results.a 
 
Entry Ligand Base Solvent Yield (%)b e.r.b 
1c L1 Cs2CO3 DMF 50 69:31 
2c L6 Cs2CO3 DME 56 22:78 
3 L1 Cs2CO3 DMF 58 69:31 
4 L1 Cs2CO3 ACN 62 73:27 
5 L1 Cs2CO3 Acetone 75 73:27 
6 L2 Cs2CO3 Acetone 90 (80) 77:23 
7 L3 Cs2CO3 Acetone 74 72:28 
8 L4 Cs2CO3 Acetone 9 51:49 
9 L5 Cs2CO3 Acetone 15 50:50 
10 L2 CsOH·H2O Acetone 87 76:24 
11 L2 DBU Acetone 88 77:23 
12d L2 Cs2CO3 Acetone 91 76:24 
13e L2 Cs2CO3 Acetone 84 76:24 
14f L2 Cs2CO3 Acetone 86 76:24 
15g L2 Cs2CO3 Acetone (89) 77:23 
a For further details on optimisation experiments, see ESI. b 
Yield and e.r. determined by SFC analysis of reaction mixtures 
with an external standard. Isolated yield in parentheses. c Experi-
ment run with NiCl2·DME (10 mol%). d Experiment run with 10 
mol% of ligand. e Experiment run with 5 mol% of NiBr2·DME and 
7.5 mol% of ligand. f Experiment run with enantiomer of substrate, 
derived from D-alanine. g Performed on a 1 mmol scale, see SI for 
details. DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene, TMG = 
1,1,3,3-tetramethylguanidine.  
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Scheme 2. Substrate scope. 
 
Isolated yields reported. Standard conditions as in Table 1, entry 6, with 11 mol% L2. Notes: a Reaction time: 64 h. b 8 mol% 4CzIPN 
used. c Reaction time: 40 h. d 1.1 equiv. of carboxylic acid and Cs2 O3 were used. e 1H-NMR yield of racemic product. Experiment run in 
DMF with NiCl2·DME (10 mol%), dtbbpy (15 mol%), Ir(dF(CF3)2bpy)2(dtbbpy)PF6 (2 mol%), 1 equiv. of imidazolic acid and Cs2 O3. Our 
standard conditions failed to deliver any product. f Experiment run with L1 as ligand. Reaction with L2 affords product in 97% chromato-
graphic yield and 57:43 e.r.. g 1H-NMR yield: 20%. 
 
Subsequent optimization experiments showed improvements 
in using NiBr2·DME as Ni source (entry 3) and acetone as sol-
vent (entries 4-5). With a better set of conditions in hand, an 
evaluation of structurally modified PyOx ligands was per-
formed (entries 6-9). The introduction of a methyl group in the 
C3 position of the pyridine ring (ligand L2) proved highly ben-
eficial in terms of reactivity (90% yield, entry 6), while also 
providing a small improvement in enantioselectivity (77:23 
e.r.). It was subsequently found that L2 provides a much more 
active catalytic system: full conversion to 2a was obtained in 4 
h instead of 15 h when compared to L1 and L6 (Figure 2). Mov-
ing the methyl to the C4 position (ligand L3) provided the same 
results as L1 (entry 7). Introducing a methyl group in C6 posi-
tion (ligand L4) or an electron-withdrawing trifluoromethyl 
group in C5 position (ligand L5) proved to be deleterious (en-
tries 8-9). Having selected L2 as the most promising ligand for 
this transformation, a final screen of bases revealed that only 
CsOH·H2O (entry 10) and DBU (entry 11) provided product 
with the same efficiency as Cs2CO3. Finally, reducing the lig-
and:Ni ratio to 1:1 provided the same results as the initial 1.5:1 
ratio (entry 12), while reducing the loading of the Ni catalyst 
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from 10 to 5% afforded a slightly reduced 84% yield (entry 13). 
If the enantiomer of the substrate, derived from D-alanine, is 
employed the same enantiomer of the product is obtained with 
the same stereoselectivity (entry 14), confirming the enantio-
convergent nature of the process. The effect of temperature was 
also evaluated, but minimal differences in enantioselectivity 
were observed between 0 °C and 35 °C (see ESI, Table S9). 
Control experiments confirmed the necessity of all the reaction 
elements to the success of the transformation (see ESI, Table 
S8). Pleasingly, the reaction can be successfully scaled up from 
0.2 mmol to a more synthetically useful 1.0 mmol scale, afford-
ing 2a in 89% yield and 77:23 e.r., with no loss in reactivity or 
enantioselectivity (entry 15). 
  
Figure 2. Progression of reaction when using different ligands. 
Conditions as in Table 1, entries 5 (L1), 6 (L2) and 2 (L6). Yield of 
2a determined by SFC analysis of reaction mixtures using an ex-
ternal standard. 
With optimised conditions in hand, we next sought to define 
the scope of the methodology (Scheme 2). Inspired by the good 
stereocontrol obtained by the Fu and MacMillan groups on car-
bamate-protected aminoacids (Scheme 1b), we hypothesised 
that the carbamate could play a role as a coordinating moiety in 
such systems.10d We thus envisaged that the introduction of a 
directing group in C2 position on the heterocycle might have 
similar benefits.20 Such a system could provide an additional 
binding site for the heterocyclic-alkyl fragment to the nickel 
centre, increasing rigidity in some key intermediate complexes 
of the catalytic cycle (Scheme 3, hypothetical intermediate A). 
Scheme 3. Hypothetical chelation of the alkyl radical to Ni 
thanks to a directing group on the heterocyclic moiety. 
 
Indeed, an increased stereocontrol is observed when a car-
bonyl functionality is introduced on the heterocycle: ketone 2b 
and amide 2d are obtained in 92:8 and 91:9 e.r. respectively. 
However, reduced reactivity is observed, and extended reaction 
times are required to observe useful yields. An ester group does 
not seem to provide directing group assistance, for 2c is ob-
tained with 72:28 e.r., similarly to the model compound. A pyr-
idine ring can also behave as a directing group: derivative 2e is 
obtained in improved 85:15 e.r. and 22% yield. Unfortunately, 
imidazole-bearing etomidate analogue 2f could not be obtained 
with our method. If the reaction is run with an achiral ligand a 
13% NMR yield is obtained. This suggests that a designed cat-
alytic system might be needed for efficient reactivity of imid-
azole-containing substrates.21 Pleasingly, pyrazole-containing 
derivative 2g was obtained in 57% yield and 68:32 e.r.; as ex-
pected, positioning the acetyl group away from the reaction 
centre does not provide directing group assistance. Replacing 
the pyrrole with a bulkier indole ring, as for compound 2h, has 
a detrimental effect on enantioselectivity when the ligand em-
ployed is L2. While the reaction goes to completion, the prod-
uct obtained is almost racemic; however, if  L1 is used some 
stereocontrol is restored (71:29 e.r.) whilst maintaining good 
reactivity (77% yield). As further evidence of the concept of 
using a directing group, azaindole derivative 2i was obtained in 
comparable 65% yield and 83:17 e.r. even when using L2. The 
coordinating ability of the additional nitrogen centre must thus 
overcome the steric hindrance provided by the two fused rings. 
A xanthine system, such as in 2j, is also tolerated (77:23 e.r.), 
even if the product is obtained with 27% yield. A limitation is 
found when turning to carbazole derivative 2k. Employing ei-
ther L2 or L1 as ligands, an almost racemic compound is ob-
tained with a good yield. Phthalimide-containing derivative 2l 
and the simple diaryl compound 2m were obtained in trace 
amount using our standard conditions. 
Variations in the alkyl chain were then explored: groups other 
than methyl such as n-butyl, benzyl and 3-methoxy-3-oxopro-
pyl are tolerated on the substrate, affording products 2n, 2o and 
2q in 81-87% yield and enantioselectivities close to the model 
susbtrate’s (76:24 e.r. on average). Unfortunately, valine-de-
rived compound 2p was obtained with very low stereocontrol 
in 63% yield, suggesting β-substitution on the alkyl chain is not 
well tolerated. Azaindole derivative 2r, bearing a n-butyl alkyl 
chain, could also be obtained with results comparable to those 
for 2i (62% yield, 82:18 e.r.).  
Lastly, an evaluation of aryl bromides was also performed. A 
range of para-substituted electron-poor derivatives can be suc-
cessfully coupled with the model pyrrole carboxylic acid 1a. 
Ketone 2s, aldehyde 2t, benzothiazole 2u and oxadiazole 2v can 
all be obtained in very good yields (75-88%) and enantioselec-
tivity comparable to the model susbtrate’s (78:22 e.r. on aver-
age). Interestingly, the azole groups in 2u and 2v are well tol-
erated, allowing the preparation of these drug-like compounds 
in an efficient manner. Other substitution patterns, including or-
tho- (2w), meta,meta- (2x) and 2-pyridine substitution (2y), 
seem more problematic, affording products in reduced yields 
and/or enantioselectivity. The use of electron-neutral or elec-
tron-rich aryl bromides is not advised, as poor yields are ob-
tained in the former case (compound 2z, 10% yield), while only 
traces of the desired reactivity are found in the latter (compound 
2aa). Compound 2ab, bearing an acetyl directing group, was 
obtained with 94:6 e.r. but in 34% yield, similarly to 2b.  
In summary, we have demonstrated how α-heterocyclic car-
boxylic acids can be successfully employed as substrates for the 
preparation of enantioenriched chiral N-benzylated heterocy-
cles, an important class of compounds now accessible using Ni–
photoredox dual catalysis. A variety of substrates was examined 
to find useful trends and limitations. Notably, the combination 
of yields and enantioselectivity obtained with cheap and easily 
obtainable chiral PyOx ligands provides large advances over a 
comparable racemic synthesis (see ESI, Table S12).22 Subse-
quent studies will address current issues, particularly regarding 
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the reduced reactivity of some heterocyclic substrates (e.g. im-
idazoles) and aryl halides. We anticipate that the modular and 
stereoconvergent nature of this strategy will allow rapid screen-
ing and diversification of structures, especially useful in a drug 
discovery setting, exploiting the commercial accessibility of 
aryl bromides and carboxylic acid precursors.  
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